Randall Marshall is a Research Advisor in Clinical Development. Randall is currently Chief Medical Officer of EuMentis Therapeutics, and a CMO advisor for Sophrosyne and Lactocore therapeutics. Dr. Marshall brings 25+ years of experience across all aspects of clinical research, and has led programs in neurological and psychiatric disorders, in rare disease, and in hepatology and pediatric oncology. Prior to that, he held medical leadership roles of increasing responsibility at Sepracor, Sunovion, Euthymics, Neurovance, and Retrophin including co-founding ProTara Therapeutics. Randall has published more than 130 peer-reviewed publications, book chapters or books in his fields of expertise.
Dr. Marshall earned his MD at Johns Hopkins University and completed his psychiatry residence and research fellowship at Columbia University, where he attained Associate Professor.